Gómez-Almaguer David, Gómez-De León Andrés, Colunga-Pedraza Perla R, Cantú-Rodríguez Olga G, Gutierrez-Aguirre César Homero, Ruíz-Arguelles Guillermo
Hematology Service, Facultad de Medicina y Hospital Universitario 'Dr. Jose Eleuterio Gonzalez', Universidad Autónoma de Nuevo León, Francisco I. Madero Ave., Mitras Centro, Monterrey 64460, Nuevo León, México.
Hematology Service, Hospital Universitario 'Dr. José Eleuterio González', Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, México.
Ther Adv Hematol. 2022 Feb 26;13:20406207221080739. doi: 10.1177/20406207221080739. eCollection 2022.
Hematopoietic stem-cell transplantation (HSCT) is usually performed in well-equipped units inside a hospital. The cost of this in-hospital transplant is usually very high; therefore, this procedure is more difficult to perform in low- and middle-income countries. Autologous outpatient HSCT is now a common procedure; however, outpatient allogeneic transplants are more complicated. Only a few centers in the world have incorporated outpatient HSCT. This transplant requires special adaptation, like a day hospital, careful selection of patients, oral medications, and the patient must live relatively close to the hospital. The results until now suggest that this outpatient transplant is factible and similar to inpatient HSCT. The objective was to review and describe the different methods and results following an outpatient allogeneic-HSCT strategy.
造血干细胞移植(HSCT)通常在医院内设备完善的科室进行。这种院内移植的费用通常非常高;因此,在低收入和中等收入国家开展该手术更加困难。自体门诊HSCT目前是一种常见的手术;然而,门诊异体移植则更为复杂。世界上只有少数几个中心开展了门诊HSCT。这种移植需要特殊的调整,比如日间医院、仔细挑选患者、口服药物,而且患者必须居住在离医院相对较近的地方。目前的结果表明,这种门诊移植是可行的,且与住院HSCT相似。目的是回顾和描述门诊异体HSCT策略后的不同方法和结果。